Diabetic Nephropathy as a Result of Uncontrolled Hyperglycemia
-
Published:2024-06-24
Issue:1
Volume:18
Page:e07716
-
ISSN:1981-982X
-
Container-title:Revista de Gestão Social e Ambiental
-
language:
-
Short-container-title:RGSA
Author:
Aquino Camila Silva deORCID, Miranda Estênio GabrielORCID, Ribeiro Júnior Francisco José PascoalORCID, Lucena Hérika Juliana de AraújoORCID, Oliveira Jéssica Pará Amaral deORCID, Lima Neto João FerreiraORCID, Pinho Lênio Airam deORCID, Rodrigues Miguel ValentimORCID, Silvestre Pedro Henrique BorgesORCID, Saijo Rafaela de Oliveira EstevãoORCID, Bezerra Roberta FernandesORCID
Abstract
Objective: to investigate the relationship between uncontrolled hyperglycemia and the development of diabetic nephropathy.
Methods: Integrative review of the literature, carried out in June 2024, in the virtual databases Virtual Health Library, Medical Literature Analysis and Retrieval System Online and Google Scholar using the descriptors “Diabetic Nephropathies”, “Glomerular Filtration Rate”, “Hyperglycemia” and “Diabetes Mellitus”, as well as “Diabetic Nephropathies”, “Glomerular Filtration Rate”, “Hyperglycemia” and “Diabetes Mellitus” selected by DeCS and MeSH Descriptors, related to the Boolean operator AND in all databases.
Results and Discussion: after completing the methodological procedures, 12 articles available on the VHL Portal, in the PubMed, VHL and Google Scholar databases were selected, which show that diabetic nephropathy is a serious and common complication of diabetes mellitus, characterized due to the progressive impairment of renal function, being one of the main causes of chronic kidney disease and terminal renal failure worldwide. The development of diabetic nephropathy is linked to glycemic control, with chronic hyperglycemia being a crucial factor in the pathogenesis of this condition.
Final Considerations: strict control of blood glucose and blood pressure, combined with pharmacological interventions and lifestyle modifications, constitutes the basis of effective management of diabetic nephropathy.
Publisher
RGSA- Revista de Gestao Social e Ambiental
Reference21 articles.
1. Bommel, E. J. M. V.; Muskiet, M. H. A.; Baar, M. J. B. V.; Tonneijck, L.; Smits, M. M.; Emanuel, A. L et al. The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial. Kidney International, v. 97, n. 1, p. 202–212, Jan. 2020. 2. Defronzo, R. A.; Reeves, W. B.; Awad, A. S. Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors. Nat Rev Nephrol, p. 319–334, 2021. 3. Gerin, L.; Antonini, M.; Santos, K. DA. S.; Gir, E.; Reis, R. K. O conhecimento dos profissionais de saúde sobre vacinação de pessoas vivendo com HIV – uma revisão integrativa. Escola Anna Nery, v. 26, p. e20210210, 2022. 4. Garofalo, C.; Borrelli, S.; Liberti, M. E.; Andreucci, M.; Conte, G.; MINUTOLO, R et al. SGLT2 Inhibitors: Nephroprotective Efficacy and Side Effects. Medicina, v. 55, n. 6, p. 268, 1 jun. 2019. 5. Haber, L. S. DE. A.; Coscina, G. L.; Melo, R. F. DE.; Haber, J. F. DOS. S.; Chagas, E. F. B. Creatinina sérica e taxa de filtração glomerular pela equação ckid em crianças e adolescentes com dm1: estudo observacional. International Standart Serial Number Brazil, v, 3, n. 2, p. 145-150, 2023.
|
|